Researchers at University of California San Diego School of Medicine identified new therapeutic targets for gastrointestinal stromal tumors (GISTs) that could lead to new treatment options for patients.
UC San Diego researchers report that individual immune response to SARS-CoV-2 may be limited by a set of variable genes that code for cell surface proteins essential for the adaptive immune system. The finding may help explain why COVID-19 immunity varies by individual.
It’s been more than a year since our news feeds first alerted us to a mysterious illness and its rapid spread. Since then, the COVID-19 pandemic has transformed our lives and touched every part of the globe.
The first photo in Paige Nguyen’s pandemic diary is full of complexities. As a first-year student, Nguyen has yet to experience a full campus teeming with activity, but one assignment in her History of Public Health class— the term project “Diaries in the time of Plague”—brought this moment into sharp focus.
Engineers at the University of California San Diego have created a four-legged soft robot that doesn’t need any electronics to work. The robot only needs a constant source of pressurized air for all its functions, including its controls and locomotion systems.
The Psychedelics and Health Research Initiative at UC San Diego has received a $1.3 million grant from the Steven & Alexandra Cohen Foundation to fund a clinical trial investigating the therapeutic potential of psilocybin in treating phantom limb pain.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
